initi coverag outperform
recoveri first chapter
bottom line initi coverag outperform rate
pt tandem tradit recoveri stori despit trade
year date momentum evid revenu increas y/i surpass
street gross margin rose bp long-term outlook
promis given manufactur consolid pump util increas
tandem product pipelin differenti clean balanc sheet thu
ad diabet franchis
diabet arena undergon signific advanc acceler
adopt insulin pump benefit user-friendli fda new product
innov improv reimburs time expect
insulin-depend patient migrat pump slew new autom
pump enter market exampl current type diabet
util pump therapi despit ampl clinic data market expand
manufactur consolid roch anima exit market
leav tandem primari pump manufactur arena
tandem increas market share
expect increas
tandem consumer-focus approach develop slim pump offer
touchscreen automat softwar upgrad launch august sixth-
gener slim basal-iq includ insulin-suspend featur leverag
partnership elimin fingerstick look forward focu shift
toward control-iq pump sport micro pump add
intern market opportun tandem first full year plu pump
replac cycl believ even valuat still attract
model revenu ep loss
ep loss
posit ep current trade ev/revenu versu
peer group averag increas revenu versu despit multipl
believ tndm product differenti market momentum product pipelin
clean balanc sheet zero debt posit well follow in-depth
valuat analysi see page initi coverag outperform
pleas refer page import disclosur includ analyst certif
tandem beyond recoveri stori
believ compani continu posit
surpris bia given strong long-term outlook
financ concern behind tandem
pipelin expand footprint
intern march toward profit
